| 000 | 01144 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250516092522.0 | ||
| 264 | 0 | _c20121019 | |
| 008 | 201210s 0 0 eng d | ||
| 022 | _a2159-8290 | ||
| 024 | 7 |
_a10.1158/2159-8290.CD-11-0151 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCapdevila, Jaume | |
| 245 | 0 | 0 |
_aA shining light in the darkness for the treatment of pancreatic neuroendocrine tumors. _h[electronic resource] |
| 260 |
_bCancer discovery _cAug 2011 |
||
| 300 |
_a213-21 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDrug Discovery _xmethods |
| 650 | 0 | 4 | _aEverolimus |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xadverse effects |
| 650 | 0 | 4 |
_aNeuroendocrine Tumors _xdrug therapy |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPyrroles _xadverse effects |
| 650 | 0 | 4 |
_aSirolimus _xadverse effects |
| 650 | 0 | 4 | _aSunitinib |
| 700 | 1 | _aTabernero, Josep | |
| 773 | 0 |
_tCancer discovery _gvol. 1 _gno. 3 _gp. 213-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/2159-8290.CD-11-0151 _zAvailable from publisher's website |
| 999 |
_c21781912 _d21781912 |
||